Spotlight on Skin Cancer NZ newsletter

In the April edition of Spotlight, we shared:

• The latest on the NZ Skin Cancer Summit.
• A reminder of the Skin Cancer NZ AGM (19 June).
• Pharmac’s decision to widen funded access to nivolumab and ipilimumab for eligible people with resectable stage IIIB and IV melanoma.
• HealthCert's webinar replay on melanoma pathophysiology, UVA exposure and prevention.

In the March edition of Spotlight, we shared:

• The latest on the NZ Skin Cancer Summit - with early bird registration and abstracts closing soon.
• A save-the-date for the Skin Cancer NZ AGM (19 June).
• Updates on our rebrand, including new email addresses to add to your address book.
• Plus highlights from upcoming events and recent research.

In the February edition of Spotlight, we shared:

• Updates on our rebrand, including our new look and ways to connect on LinkedIn.
• How to register for the 2026 New Zealand Skin Cancer Summit (18–20 June).
• Education opportunities to support confidence in diagnosing skin lesions.
• A University of Otago webinar recording, SunSmart or SunSlack?, exploring New Zealanders’ attitudes, behaviours, and gaps in understanding around UV protection.

In the January edition of Spotlight, we shared:

• An opportunity to help shape our priorities for 2026.
• Upcoming learning opportunities from Skin Cancer NZ.
• A HealthCert webinar replay on skin cancer in skin of colour, exploring diagnostic challenges and common clinical pitfalls.
• Recent media coverage on sun safety.
• Other events and research updates.

If you would like access to earlier editions, please contact us.